Close

Interviews

Anand Modi, VP Sales India at Tracelink, on Generic Companies In the Pharma Sector

How are Indian generics companies fairing in the competitive race to serialize and ship medicines to the US?Though the serialization deadline has passed for the Drug Supply Chain Security Act (DSCSA)in the US, companies across the globe are still...

Idifarma with its new automated capsule

1. What does this approval mean to Idifarma?It’s a great opportunity for growth, boosting our GMP capabilities with capsule filling in addition to immediate and modified release tablets. It is also a significant milestone in our journey so far,...

Innovative creative solutions to integrate development cycles

1. Will this merger change any of your organizational structure and framework?The partnership is not a merger, it is a collaboration between Recipharm and the Clinical Trial Consultants (CTC) to allow both companies to offer a complete service from...

Yesterday, Today, Tomorrow ChargePoint Technology

What does this certification mean to you?Achieving the highest level of certification in Atmosphere Explosive (ATEX) and International Electro Commission (IEC) Explosive (Ex) equipment,combined with recent investment in our Liverpool facility, forms an important part of our strategy to...

A New Approach To Pharmacovigilance

1.Quanticate has just completed an investment initiative to upgrade its pharmacovigilance safety data base,how will the new system simplify event reporting in the EU and enhance data availability to stake holders? The upgrade of our safety database ties in with...

Clinical Trial Disclosure Maturity Assessment Process Disclosed By TrialScope

1. In an environment where trial data is made available through peer reviewed articles how effective is clinical trial disclosure maturity assessment with increased risk, complexity and costs to assess global disclosure processes? The Clinical Trial...

Global Clinical Trials A Insiders Take

What are the current problems or challenges faced in clinical trial payments process?There are countless challenges around clinical trial payments, but they can be best categorized into two core themes – the increasing administrative burdens around processing and reconciling...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read